American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S340-S344 , December 2008

The clinical content of preconception care: genetics and genomics

  • Benjamin D. Solomon, MD

      Affiliations

    • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
    • ,
  • Brian W. Jack, MD

      Affiliations

    • Department of Family Medicine, Boston University Medical Center, Boston, MA
    • ,
  • W. Gregory Feero, MD, PhD

      Affiliations

    • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
    • Corresponding Author InformationReprints: W. Gregory Feero MD, PhD, Chief, Genomic Healthcare Branch, National Human Genome Research Institute, Building 31, Room 4B09, 31 Center Dr, Bethesda, MD 20892

Received 17 June 2008 ,Revised 22 September 2008 ,Accepted 25 September 2008.

References 

  1. American College of Obstetricians and Gynecologists. ACOG committee opinion no.: 313: the importance of preconception care in the continuum of women's health care. Obstet Gynecol. 2005;106:665–666
  2. Dolan SM, Moore C. Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects. Pediatrics. 2007;120(Suppl 2):S66–S70
  3. Koscica KL, Canterino JC, Harrigan JT, Dalaya T, Ananth CV, Vintzileos AM. Assessing genetic risk: comparison between the referring obstetrician and genetic counselor. Am J Obstet Gynecol. 2001;185:1032–1034
  4. Hogge JS, Hogge WA. Preconception genetic counseling. Clin Obstet Gynecol. 1996;39:751–762
  5. Wattendorf DJ, Hadley DW. Family history: the three-generation pedigree. Am Fam Physician. 2005;72:441–448
  6. Pellestor F, Andréo B, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from the cytogenetic studies of human oocytes. Eur J Med Genet. 2006;49:103–116
  7. Schrander-Stumpel C. Preconception care: challenge of the new millennium?. Am J Med Genet. 1999;89:58–61
  8. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet. 2004;125:12–21
  9. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat Rev Neurosci. 2006;7:724–731
  10. Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:1003–1026
  11. Committee on Genetics, American College of Obstetricians and Gynecologists. ACOG committee opinion no.: 325, December 2005: update on carrier screening for cystic fibrosis. Obstet Gynecol. 2005;106:1465–1468
  12. Kaplan F. Tay-Sachs disease carrier screening: a model for prevention of genetic disease. Genet Test. 1998;2:271–292
  13. ACOG Committee on Genetics. ACOG committee opinion no.: 298, August 2004: prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol. 2004;104:425–428
  14. ACOG Committee on Genetics. ACOG committee opinion no.: 318, October 2005: screening for Tay-Sachs disease. Obstet Gynecol. 2005;106:893–894
  15. Gross SJ, Pletcher BA, Monaghan KG Professional Practice and Guidelines Committee. Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med. 2008;10:54–56
  16. Cao A, Rosatelli MC, Monni G, Galanello R. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am. 2002;29:305–328vi-vii
  17. ACOG Committee. ACOG practice bulletin no.: 64: clinical management guidelines for obstetrician-gynecologists (replaces committee opinion no.: 238, July 2000): hemoglobinopathies in pregnancy. Obstet Gynecol. 2005;106:203–210
  18. Rappaport VJ, Velazquez M, Williams K. Hemoglobinopathies in pregnancy. Obstet Gynecol Clin North Am. 2004;31:287–317vi
  19. Monaghan KG, Feldman GL, Palomaki GE, Spector EB Ashkenazi Jewish Reproductive Screening Working Group; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population. Genet Med. 2008;10:57–72
  20. American College of Medical Genetics. Technical standards and guidelines for CFTR mutation testing. 2006. http://www.acmg.net/Pages/ACMGActiviites/stds-2002/cf.htmAccessed Oct. 27, 2008
  21. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–465
  22. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005;7:584–587
  23. Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenat Diagn. 2007;27:991–994
  24. Shaffer LG American College of Medical Genetics, Professional Practice and Guidelines Committee. American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Genet Med. 2005;7:650–654
  25. Vallance H, Ford J. Carrier testing for autosomal-recessive disorders. Crit Rev Clin Lab Sci. 2003;40:473–497
  26. Michaelides K, Tuddenham EG, Turner C, Lavender B, Lavery SA. Live birth following the first mutation specific pre-implantation genetic diagnosis for haemophilia A. Thromb Haemost. 2006;95:373–379
  27. American College of Obstetricians and Gynecologists. ACOG practice bulletin no.: 24: management of recurrent pregnancy loss (replaces technical bulletin no.: 212, September 1995). Int J Gynaecol Obstet. 2002;78:179–190
  28. Dunlop AL, Jack BW, Bottalico JN, et al. The clinical content of preconception care: women with chronic medical conditions. Am J Obstet Gynecol. 2008;199:S310–S327
  29. Escudero T, Lee M, Stevens J, Sandalinas M, Munne S. Preimplantation genetic diagnosis of pericentric inversions. Prenat Diagn. 2001;21:760–766
  30. Munne S, Scott R, Sable D, Cohen J. First pregnancies after preconception diagnosis of translocations of maternal origin. Fertil Steril. 1998;69:675–681
  31. Munne S, Sandalinas M, Escudero T, Fung J, Gianaroli L, Cohen J. Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril. 2000;73:1209–1218
  32. Powars DR, Sandhu M, Niland-Weiss J, Johnson C, Bruce S, Manning PR. Pregnancy in sickle cell disease. Obstet Gynecol. 1986;67:217–228
  33. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001;98:28–35
  34. Rouse B, Azen C. Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy. J Pediatr. 2004;144:235–239
  35. Koch R, Hanley W, Levy H, et al. The Maternal Phenylketonuria International study: 1984-2002. Pediatrics. 2003;112:1523–1529
  36. Pletcher BA, Gross SJ, Monaghan KG, Driscoll DA, Watson MS. The future is now: carrier screening for all populations. Genet Med. 2008;10:33–36

 Supported in part by the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.

 Conflict of Interest: Benjamin D. Solomon, MD; Brian W. Jack, MD; and W. Gregory Feero, MD, PhD have no conflict of interest including grants, honoraria, advisory board membership, or share holdings.

PII: S0002-9378(08)01095-8

doi: 10.1016/j.ajog.2008.09.870

American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S340-S344 , December 2008

Article Tools